26 September 2022
: Case report
Alleviation of Post-COVID-19 Cognitive Deficits by Treatment with EGb 761®: A Case Series
Unusual or unexpected effect of treatment
Udo A. Zifko1E*, Muhammad Yacob1E, Benedikt J. Braun1BE, Gunnar P.H. Dietz2EFDOI: 10.12659/AJCR.937094
Am J Case Rep 2022; 23:e937094
Figure 1. The COVID-19 pandemic left many patients with long-lasting cognitive or psychiatric symptoms. Here, we report a substantial alleviation of those symptoms in 5 patients after treatment with Ginkgo extract EGb 761®. Indicated below the Ginkgo leaf is the structure of bilobalide B, a terpene lactone which is one of several hundred compounds present in EGb 761®. Drawing by Ulrike Möltgen.